Bayer launches Felujit fungicide for paddy cultivation, offering superior protection against sheath blight with dual-action ...

While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...

BAYRY secures first global approval for Lynkuet in the UK, a hormone-free treatment for menopause-related hot flashes.

Bayer's Louisiana glyphosate plant is back online, but the glyphosate shortage is industry wide as one Extension weed scientist says growers need to make multiple crop chemistry plans for the next ...

DEKALB and Asgrow are rolling out 43 new corn and soybean products for 2026 featuring advanced pest and disease protection.

An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.

The Medicines and Healthcare products Regulatory Agency (MHRA) has cleared the oral neurokinin (NK) 1 and 3 antagonist, under the Lynkuet brand name, for the treatment of moderate to severe vasomotor ...

Berlin: Bayer has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA, regulatory authority ...

Singapore-based market expansion services provider DKSH Business Unit Healthcare announced a partnership with Germany’s Bayer ...

The Ministry of Business and Made in Italy has awarded Bayer Italia the "Excellence of the Production System and Made in ...

Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...

Bayer, a global enterprise with core competencies in the life science fields of agriculture and healthcare, announced the ...